Insider trades
Jane Wasman, Director of Rigel Pharmaceuticals RIGL, has filed 1 purchase and 0 sales on the open market. The latest trade was on 05/15.
Jane Wasman
Director
- Company
- Rigel Pharmaceuticals RIGL
- First filing
- 23/01/11
- Trades
- 16 trades
- Buys / sales
- 1 / 0
- 12-month net buying
- No record
- Last trade
- 05/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 25/05/30 | 25/06/02 | 20,000 sh | $1.69 | $33,800 | +192.3% |
